These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24472579)

  • 21. GABA
    Müller Herde A; Benke D; Ralvenius WT; Mu L; Schibli R; Zeilhofer HU; Krämer SD
    Neuroimage; 2017 Apr; 150():279-291. PubMed ID: 28192273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice.
    Behlke LM; Foster RA; Liu J; Benke D; Benham RS; Nathanson AJ; Yee BK; Zeilhofer HU; Engin E; Rudolph U
    Neuropsychopharmacology; 2016 Sep; 41(10):2492-501. PubMed ID: 27067130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
    Whittemore ER; Yang W; Drewe JA; Woodward RM
    Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptors.
    Acri JB; Wong G; Lyon T; Witkin JM; Basile AS
    Neuroscience; 1997 Mar; 77(2):371-8. PubMed ID: 9472397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.
    Dawson GR; Maubach KA; Collinson N; Cobain M; Everitt BJ; MacLeod AM; Choudhury HI; McDonald LM; Pillai G; Rycroft W; Smith AJ; Sternfeld F; Tattersall FD; Wafford KA; Reynolds DS; Seabrook GR; Atack JR
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1335-45. PubMed ID: 16326923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of treatment and activation of α1-containing GABAA receptors variably affect the level of anxiety and seizure susceptibility after diazepam withdrawal in rats.
    Kovačević J; Timić T; Tiruveedhula VV; Batinić B; Namjoshi OA; Milić M; Joksimović S; Cook JM; Savić MM
    Brain Res Bull; 2014 May; 104():1-6. PubMed ID: 24695241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABAA receptors.
    Cagetti E; Liang J; Spigelman I; Olsen RW
    Mol Pharmacol; 2003 Jan; 63(1):53-64. PubMed ID: 12488536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
    Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
    Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
    Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebellar granule-cell-specific GABAA receptors attenuate benzodiazepine-induced ataxia: evidence from alpha 6-subunit-deficient mice.
    Korpi ER; Koikkalainen P; Vekovischeva OY; Mäkelä R; Kleinz R; Uusi-Oukari M; Wisden W
    Eur J Neurosci; 1999 Jan; 11(1):233-40. PubMed ID: 9987027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
    Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
    Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
    Kralic JE; O'Buckley TK; Khisti RT; Hodge CW; Homanics GE; Morrow AL
    Neuropharmacology; 2002 Sep; 43(4):685-94. PubMed ID: 12367614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.
    Auta J; Impagnatiello F; Kadriu B; Guidotti A; Costa E
    Neuropharmacology; 2008 Aug; 55(2):148-53. PubMed ID: 18555494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha2-gamma-Aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo.
    Täuber M; Calame-Droz E; Prut L; Rudolph U; Crestani F
    Eur J Neurosci; 2003 Nov; 18(9):2599-604. PubMed ID: 14622161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.